MS

Morgan Stanley
D

MS

Arincen79/100B
181.420
USD
-1.04
(-0.57%)
Post Trading·181.950USD+0.530(+0.29%)
Last updated: · Delayed 15 min
Fair value193.70Plus-6%116Price 181.42269
Q4 FY2026 · Earnings report
EPS estimate 2.93Revenue estimate 20.26B
OverviewFinancialsNewsForecastEarningsDividendsCompany

Morgan Stanley cash on hand 1985–2026

Morgan Stanley had 1.01T USD in cash and short-term investments on 30 September 2026, up 882.3% on a year before. At the end of fiscal year 2025 it had 539.97B USD.

Last updated 8 Nov 2026 · Next report 14 Jan 2027

Cash on hand

Growth

Fiscal yearPeriod endingCash on handGrowthTotal debtNet cash
Latest quarter30 Sept 20261.01T+882.27%529.61B482.60B
FY202531 Dec 2025539.97B+34.46%475.56B64.41B
FY202431 Dec 2024401.59B-13.06%360.49B41.10B
FY202331 Dec 2023461.89B-1.27%339.04B122.85B
FY202231 Dec 2022467.86B-6.49%308.75B159.11B
FY202131 Dec 2021500.35B+5.51%305.36B194.99B
FY202031 Dec 2020474.23B+28.58%283.53B190.70B
FY201931 Dec 2019368.83B+3.23%261.53B107.31B
FY201831 Dec 2018357.29B+13.72%248.89B108.40B
FY201731 Dec 2017314.17B-1.24%260.28B53.90B
FY201631 Dec 2016318.11B-0.71%251.72B66.39B
FY201531 Dec 2015320.38B-13.03%221.41B98.96B
FY201431 Dec 2014368.39B-7.16%237.07B131.33B
FY201331 Dec 2013396.83B+7.72%315.61B81.22B
FY201231 Dec 2012368.38B+49.38%310.11B58.27B
FY201131 Dec 2011246.60B-1.82%382.29B-135.69B
FY201031 Dec 2010251.18B+22.98%434.72B-183.54B
FY200931 Dec 2009204.24B-10.24%432.43B-228.19B
FY200831 Dec 2008227.54B+4.77%330.36B-102.82B
FY200730 Nov 2007217.19B-5.15%450.70B-233.51B
FY200630 Nov 2006228.99B-7.10%567.26B-338.28B
FY200530 Nov 2005246.48B+58.15%480.91B-234.42B
FY200430 Nov 2004155.85B+189.55%566.54B-410.69B
FY200330 Nov 200353.83B-12.74%258.68B-204.85B
FY200230 Nov 200261.69B+17.96%371.93B-310.25B
FY200130 Nov 200152.29B+13.32%284.82B-232.52B
FY200030 Nov 200046.15B+21.53%241.28B-195.14B
FY199930 Nov 199937.97B+124.97%233.26B-195.29B
FY199830 Nov 199816.88B+104.46%202.89B-186.01B
FY199730 Nov 19978.26B+312.92%196.89B-188.63B
FY199631 Dec 19962.00B+36.51%27.62B-25.62B
FY199531 Dec 19951.46B+9.77%18.00B-16.53B
FY199431 Dec 19941.33B+60.68%14.05B-12.72B
FY199331 Dec 1993830.30M-98.87%11.17B-10.34B
FY199231 Jan 199373.69B+24.64%66.67B7.03B
FY199131 Dec 199159.12B+17.79%51.95B7.17B
FY199031 Dec 199050.19B+0.61%44.40B5.79B
FY198931 Dec 198949.89B—46.55B3.34B
FY198831 Dec 19880.00—814.80M-814.80M
FY198731 Dec 19870.00—582.60M-582.60M
FY198631 Dec 19860.00—539.20M-539.20M
FY198531 Dec 19850.00—358.00M-358.00M

Figures in USD at the end of each period. Net cash is cash and short-term investments less total debt; book value per share is on the diluted share count. The latest column is the most recent quarter.

See also:Revenue,Net income,EPS,Shares outstanding,Operating income,Total debt,Free cash flow,Stock buybacks,Balance sheet

Common questions about Morgan Stanley's cash

Source: Financial Modeling Prep

Smarter Decisions,Together
FacebookTwitterYoutubeInstagramLinkedIn
App Store
iOS
Google Play
Android

Risk Disclosure: Trading in financial instruments involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks. Never invest money you cannot afford to lose, and carefully assess the suitability of complex products such as CFDs and derivatives in light of your financial situation. Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed. Arincen would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes.

Arincen and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website. It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Arincen and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website. Arincen may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.

© 2026 - Arincen L.L.C-FZ - License No. 2420098.01. All Rights Reserved.